Effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in women with breast cancer-Reference-Cited by-同舟云学术

Effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in women with breast cancer

Published:2023-08 Issue: Volume:228 Page:46-53
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Bosch Floris,Mulder Frits,Franken Linda,Willemsen Annelieke,Rentinck Marjolein,van den Berg Pieter,Bakker Sylvia Luykx-de,van der Velden Ankie,van Es Nick,Mathôt Ron,Kamphuisen Pieter W.

Publisher

Elsevier BV

Subject

Hematology

Reference33 articles.

1. European heart rhythm association practical guide on the use of non-vitamin K antagonist Oral anticoagulants in patients with atrial fibrillation;Steffel;EP Eur.,2021

2. Venous thromboembolism prophylaxis and treatment in patients with Cancer: ASCO clinical practice guideline update;Key;J. Clin. Oncol.,2019

3. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association;Kleindorfer;Stroke.,2021

4. Pharmacokinetics and pharmacodynamics of edoxaban, a non-vitamin K antagonist Oral anticoagulant that inhibits clotting factor Xa;Parasrampuria;Clin. Pharmacokinet.,2016

5. Impact of genetic polymorphisms of ABCB1 (MDR1, P-glycoprotein) on drug disposition and potential clinical implications: update of the literature;Wolking;Clin. Pharmacokinet.,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intestinal P‐gp activity is reduced in postmenopausal women under breast cancer therapy;Clinical and Translational Science;2024-01